PPT-COVID-19 (disease) SARS-CoV-2

virus Guam Department of Public Health and Social Services Disclaimer This is a rapidly evolving situation Information and guidance are constantly changing Information presented in these slides may already be outofdate. Cleveland Clinic Foundation recently implemented a policy OF SARS-CoV-2 testing for all \npregnant patients with planned delivery or admitted for labor at obstetric units in Ohio. We
present our January 2 7 , 202 1 Page | 1 d for Standar Final 220, - 16VAC25 Infectious Disease Prevention of the SARS - CoV - 2 Virus That Causes COVID - 19 As Adopted by the Safety and Health Codes Board on January 272021Page 1d forStandarFinal 220 -16VAC25Infectious Disease Preventionofthe SARS-CoV-2 Virus That Causes COVID-19As Adopted by theSafety and Health Codes Boardon January 13 2021VIRGINIA OCCU DiagnoscsDo not re-useTo indicate the temperature limitaons in which the transport package has to be kept and handledConsult Instrucons for UseContains Sucient fxn000or estsManufacturerBatch codeUse SARS-CoV-Updated 3/2/2020Samuel R Dominguez MD PhD and Ann-Christine Nyquist MD MSPH1What is the SARS-CoV-2and where did it come fromSARS-CoV-2 previously called 2019 novel coronavirusis a coronavirus May 27. 2020. K.Dharmalingam. Asymptomatic Likely but remote. Prodromal Yes. Oligosymptomatic Yes. Polysymptomatic Yes. Spread occurs from all these groups of patients. Fauci. , for one, still believes it does.. 2019). PRESENTED BY. Image: . “Coronaviruses viewed under an electron microscope. Note the characteristic crown-like (corona) appearance” . By CDC/Dr. Fred Murphy. ETIOLOGY. Coronaviruses (. CoV. Webinar presenters:. Robert Davenport, MD University of Michigan . (rddvnprt@med.umich.edu). Alesia Kaplan, MD University of Pittsburgh . (akaplan@itxm.org). Hua Shan, MD Stanford University . (hshan@stanford.edu). Background. SARS-CoV-2 monoclonal antibody (MAB) treatments have been approved by the FDA for Emergency Use Authorization (EUA). . Casirivimab- . imdevimab. is the only MAB . that will be infused in the outpatient setting at Main Line Health to treat COVID-19 at this time.. भारतीय आयु�वि�ान अनुसंधान पररषद �वा�्य अनुसंधान ववभाग , � - CoV - 2 Patricia Slev, PhD, D(ABCC) Section Chief, Immunology, ARUP Laboratories Associate Professor, University of Utah School of Medicine patricia.slev@aruplab.com 1 DISCLOSURES P Slev None OBJEC . alberto.tommasini@burlo.trieste.it. Trieste, 24 NOVEMBRE 2021. SARS-CoV-2. Enveloped, with a . ssRNA. genome. 4 Coronavirus genera. Alphacoronavirus. (Mammals). 229E and NL63. Betacoronavirus. (Mammals). Virupaksha. A. Bastikar. 1. ; . Pramodkumar. Gupta. 2. ; Alpana V. Bastikar. 3. and Santosh S. Chhajed. 4. 1. Amity Institute of Biotechnology, Amity University, Mumbai, Maharashtra;. 2. School of Biotechnology and Bioinformatics, D. Y. . September 3, 2020. Dr. Dawn Bowdish, PhD. Canada Research Chair in Aging & Immunity. McMaster University. bowdish@mcmaster.ca. www.bowdish.ca. Twitter & Instagram: @MsMacrophage. .